Cargando…
Therapeutic Effects of Long-Term Administration of Tranilast in an Animal Model for the Treatment of Fibroids
Tranilast (N-3, 4-dimethoxycinnamoyl anthranilic acid) is an orally administered drug with antiallergic properties and approved in Japan and the Republic of Korea for the treatment of asthma and hypertrophic scars. Previous in vitro studies indicated that tranilast reduced fibroid growth through its...
Autores principales: | Chuang, Tsai-Der, Munoz, Leslie, Quintanilla, Derek, Boos, Drake, Khorram, Omid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341593/ https://www.ncbi.nlm.nih.gov/pubmed/37445642 http://dx.doi.org/10.3390/ijms241310465 |
Ejemplares similares
-
Differential Expression of Super-Enhancer-Associated Long Non-coding RNAs in Uterine Leiomyomas
por: Chuang, Tsai-Der, et al.
Publicado: (2022) -
The Influence of Race/Ethnicity on the Transcriptomic Landscape of Uterine Fibroids
por: Chuang, Tsai-Der, et al.
Publicado: (2023) -
Differential Expression of MED12-Associated Coding RNA Transcripts in Uterine Leiomyomas
por: Chuang, Tsai-Der, et al.
Publicado: (2023) -
Uricosuric targets of tranilast
por: Mandal, Asim K., et al.
Publicado: (2017) -
miR-200c Regulates IL8 Expression by Targeting IKBKB: A Potential Mediator of Inflammation in Leiomyoma Pathogenesis
por: Chuang, Tsai-Der, et al.
Publicado: (2014)